Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Caficrestat by Applied Therapeutics for Cardiomyopathy: Likelihood of Approval
Caficrestat is under clinical development by Applied Therapeutics and currently in Phase III for Cardiomyopathy. According to GlobalData, Phase III...